The Molecular Biophysics Training Program (MBTP) at the University of Washington (UW) is designed to train predoctoral students to apply state-of-art physical and quantitative approaches to the investigation of biomedically relevant systems at molecular and cellular levels. In the post-genomic era, basic and translational research in many biomedical areas will benefit from a wider application of rigorous and quantitative biophysical methods, which requires a highly trained workforce proficient in conducting research with these methods. The overarching objective of MBTP is to meet these needs by enhancing the research experience and training of selected UW predoctoral students interested in molecular biophysics and preparing them to develop a productive career in health-related research in academia, government, and the private sector. MBTP trainees are chosen each year through a rigorous selection process that identifies the top graduate students from a large pool of talented and diverse applicants admitted to UW through four interdisciplinary programs and nine departmental programs. During their graduate career, MBTP trainees are provided with structured activities to expose them to a wide range of biophysical methods, techniques, and research topics that go beyond their home graduate program. These include, but are not limited to, a bi-weekly student research presentation series, a peer-organized student journal club and discussion group, an annual retreat that involves the trainees, their advisors, and a larger local biophysics community, as well as other lectures and courses required or supported by this program and related UW departments. This Training Program plays a special role in UW by actively nucleating a cross- departmental biophysics community. It fosters close interactions among trainees and their peer pre-doctoral students, who share common interests in molecular biophysics, but are otherwise separated by departments and graduate programs. By taking advantage of a growing body of UW faculty with biophysics background, MBTP creates a unique platform, where trainees can learn about modern biophysical techniques, gain knowledge of emerging challenges in biomedical research, and build and extend their professional network. The training program has a strong record of success and impact as evidenced by the productivity of its trainees during and after graduate school and by the diverse career choices they make after they leave graduate school.

Public Health Relevance

The Molecular Biophysics Training Program is designed to train the top graduate students at the University of Washington in modern biophysics, the development and application of state-of-the-art physical and quantitative approaches to systems of biomedical importance. The training program plays a special role in the local biomedical research community by bringing together highly talented graduate students from a wide variety of disciplines, such as Biochemistry, Chemistry, Pharmacology, Microbiology, Physics, Computer Sciences, and Engineering. This interdisciplinary training experience affords future leaders of academia and industry to broaden their scientific horizons well beyond what they would normally learn in graduate school and prepare them to undertake rigorous and quantitative research, which is essential for making new discoveries in both basic sciences and biomedical applications.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM008268-31
Application #
9571523
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Flicker, Paula F
Project Start
1988-09-30
Project End
2024-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
31
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Washington
Department
Biochemistry
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Rusnac, Domni?a-Valeria; Lin, Hsiu-Chuan; Canzani, Daniele et al. (2018) Recognition of the Diglycine C-End Degron by CRL2KLHDC2 Ubiquitin Ligase. Mol Cell 72:813-822.e4
Dingens, Adam S; Acharya, Priyamvada; Haddox, Hugh K et al. (2018) Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV. PLoS Pathog 14:e1007159
Cornell, Caitlin E; Skinkle, Allison D; He, Shushan et al. (2018) Tuning Length Scales of Small Domains in Cell-Derived Membranes and Synthetic Model Membranes. Biophys J 115:690-701
Borst, Andrew J; Weidle, Connor E; Gray, Matthew D et al. (2018) Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core. Elife 7:
Leonen, Calvin Jon Antolin; Upadhyay, Esha; Chatterjee, Champak (2018) Studies of biochemical crosstalk in chromatin with semisynthetic histones. Curr Opin Chem Biol 45:27-34
Hsu, Peter L; Li, Heng; Lau, Ho-Tak et al. (2018) Crystal Structure of the COMPASS H3K4 Methyltransferase Catalytic Module. Cell 174:1106-1116.e9
Baughman, Hannah E R; Clouser, Amanda F; Klevit, Rachel E et al. (2018) HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation. J Biol Chem 293:2687-2700
Snijder, Joost; Borst, Andrew J; Dosey, Annie et al. (2017) Vitrification after multiple rounds of sample application and blotting improves particle density on cryo-electron microscopy grids. J Struct Biol 198:38-42
Xiong, Xiaoli; Tortorici, M Alejandra; Snijder, Joost et al. (2017) Glycan shield and fusion activation of a deltacoronavirus spike glycoprotein fine-tuned for enteric infections. J Virol :
Borst, Andrew J; James, Zachary M; Zagotta, William N et al. (2017) The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human ?V?3 Integrin via Steric Hindrance. Structure 25:1732-1739.e5

Showing the most recent 10 out of 165 publications